Published in J Immunol Methods on July 03, 2006
Magnetic Nanoparticles and microNMR for Diagnostic Applications. Theranostics (2012) 1.17
A CMOS Hall-Effect Sensor for the Characterization and Detection of Magnetic Nanoparticles for Biomedical Applications. IEEE Trans Magn (2011) 1.07
Magnetic sensing technology for molecular analyses. Lab Chip (2014) 1.01
Magnetic nanoparticles for biomedical NMR-based diagnostics. Beilstein J Nanotechnol (2010) 1.00
Magnetic bead-based phage anti-immunocomplex assay (PHAIA) for the detection of the urinary biomarker 3-phenoxybenzoic acid to assess human exposure to pyrethroid insecticides. Anal Biochem (2008) 0.99
Magnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring. Expert Opin Med Diagn (2011) 0.98
Design Considerations for CMOS-Integrated Hall-Effect Magnetic Bead Detectors for Biosensor Applications. J Microelectromech Syst (2013) 0.96
Optimization of antibody-conjugated magnetic nanoparticles for target preconcentration and immunoassays. Anal Biochem (2010) 0.96
Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation. Int J Nanomedicine (2010) 0.92
A 256 pixel magnetoresistive biosensor microarray in 0.18μm CMOS. IEEE J Solid-State Circuits (2013) 0.91
Magnetic Relaxation Detector for Microbead Labels. IEEE J Solid-State Circuits (2012) 0.90
Development of an ELISA-array for simultaneous detection of five encephalitis viruses. Virol J (2012) 0.86
Emerging protein array technologies for proteomics. Expert Rev Proteomics (2013) 0.85
High performance wash-free magnetic bioassays through microfluidically enhanced particle specificity. Sci Rep (2015) 0.85
On-chip magnetic separation of superparamagnetic beads for integrated molecular analysis. J Appl Phys (2010) 0.84
Secretome: clues into pathogen infection and clinical applications. Genome Med (2009) 0.82
Wireless integrated biosensors for point-of-care diagnostic applications. Sensors (Basel) (2015) 0.81
Enzyme-Linked Electrochemical Detection of PCR-Amplified Nucleotide Sequences Using Disposable Screen-Printed Sensors. Applications in Gene Expression Monitoring. Sensors (Basel) (2008) 0.75
Frequency-domain birefringence measurement of biological binding to magnetic nanoparticles. J Magn Magn Mater (2008) 0.75
Homogeneous Biosensing Based on Magnetic Particle Labels. Sensors (Basel) (2016) 0.75
Surface Functionalization Methods to Enhance Bioconjugation in Metal-Labeled Polystyrene Particles. Macromolecules (2011) 0.75
Flow-orthogonal bead oscillation in a microfluidic chip with a magnetic anisotropic flux-guide array. Biomed Microdevices (2011) 0.75
Array Biosensor for Toxin Detection: Continued Advances. Sensors (Basel) (2008) 0.75
Global spread and persistence of dengue. Annu Rev Microbiol (2008) 6.44
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis (2003) 4.29
The WHO dengue classification and case definitions: time for a reassessment. Lancet (2006) 3.69
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe (2010) 3.48
Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog (2010) 3.16
Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg (2005) 3.12
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83
Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis (2010) 2.80
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health (2006) 2.67
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog (2010) 2.62
Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg (2005) 2.49
Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg (2006) 2.39
Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis (2010) 2.33
Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J Virol (2010) 2.31
Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med (2011) 2.29
Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis (2011) 2.26
Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol (2003) 2.22
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol (2010) 2.14
The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol (2009) 2.14
Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol (2008) 2.10
Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg (2009) 1.87
Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1. Genome Res (2007) 1.81
Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology (2002) 1.81
Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol (2005) 1.79
Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis (2007) 1.71
High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis (2010) 1.70
Integration of information technologies in clinical studies in Nicaragua. PLoS Med (2007) 1.69
Convergent antibody signatures in human dengue. Cell Host Microbe (2013) 1.64
Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology (2004) 1.61
Animal models of dengue virus infection. Viruses (2012) 1.60
Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl Trop Dis (2013) 1.57
Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis (2009) 1.55
Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure. Virology (2005) 1.55
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54
Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe (2010) 1.53
Virus identification in unknown tropical febrile illness cases using deep sequencing. PLoS Negl Trop Dis (2012) 1.52
Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis (2013) 1.51
Quantitative assessment of the benefits of specific information technologies applied to clinical studies in developing countries. Am J Trop Med Hyg (2008) 1.49
Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr Infect Dis J (2007) 1.42
Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin Infect Dis (2010) 1.40
Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl Trop Dis (2012) 1.39
RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol (2006) 1.38
Y box-binding protein-1 binds to the dengue virus 3'-untranslated region and mediates antiviral effects. J Biol Chem (2007) 1.37
A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med (2014) 1.37
Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping. J Clin Microbiol (2013) 1.35
The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology (2008) 1.31
Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication. J Virol (2010) 1.31
Enhancement of dengue virus translation: role of the 3' untranslated region and the terminal 3' stem-loop domain. Virology (2004) 1.30
Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J Clin Microbiol (2013) 1.29
Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol (2005) 1.26
Early clinical features of dengue virus infection in nicaraguan children: a longitudinal analysis. PLoS Negl Trop Dis (2012) 1.25
Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J Virol (2012) 1.25
Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners. Ann N Y Acad Sci (2007) 1.25
Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency. J Gen Virol (2009) 1.25
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology (2008) 1.24
Report of an NIAID workshop on dengue animal models. Vaccine (2010) 1.23
Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol (2011) 1.22
Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One (2011) 1.20
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. PLoS Pathog (2013) 1.20
A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci (2009) 1.20
End-to-end communication in the modulation of translation by mammalian RNA viruses. Virus Res (2005) 1.20
Dengue virus modulates the unfolded protein response in a time-dependent manner. J Biol Chem (2011) 1.20
A review of biochars' potential role in the remediation, revegetation and restoration of contaminated soils. Environ Pollut (2011) 1.19
The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010. PLoS Negl Trop Dis (2013) 1.19
Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited. J Virol (2006) 1.17
DIELECTROPHORESIS-BASED MICROFLUIDIC SEPARATION AND DETECTION SYSTEMS. Int J Adv Manuf Syst (2000) 1.14
Unusual dengue virus 3 epidemic in Nicaragua, 2009. PLoS Negl Trop Dis (2011) 1.10
Oscillating kissing stem-loop interactions mediate 5' scanning-dependent translation by a viral 3'-cap-independent translation element. RNA (2006) 1.10
Predicted hexameric structure of the Agrobacterium VirB4 C terminus suggests VirB4 acts as a docking site during type IV secretion. Proc Natl Acad Sci U S A (2005) 1.08
Index cluster study of dengue virus infection in Nicaragua. Am J Trop Med Hyg (2010) 1.08
Magnetic resonance imaging of massive ovarian edema in pregnancy. J Comput Assist Tomogr (2010) 1.08
Conformational changes in the solution structure of the dengue virus 5' end in the presence and absence of the 3' untranslated region. J Virol (2008) 1.07
Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol (2012) 1.05
Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis (2010) 1.05
Translation efficiency determines differences in cellular infection among dengue virus type 2 strains. Virology (2003) 1.04
Integrated microfluidic bioprocessor for solid phase capture immunoassays. Lab Chip (2011) 1.04
Control of dengue virus translation and replication. Curr Top Microbiol Immunol (2010) 1.04
Characterization of Aedes aegypti (Diptera: Culcidae) production sites in urban Nicaragua. J Med Entomol (2007) 1.04
S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells. J Virol (2005) 1.03
Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses. Emerg Infect Dis (2016) 1.03
Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis (2013) 1.03
Severe coinfections of dengue and pandemic influenza A H1N1 viruses. Pediatr Infect Dis J (2010) 1.03
Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response. Am J Trop Med Hyg (2004) 1.02
Improvement in hospital indicators after changes in dengue case management in Nicaragua. Am J Trop Med Hyg (2009) 1.02
Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology (2012) 1.01
Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children. PLoS Negl Trop Dis (2012) 0.99
From construction workers to architects: developing scientific research capacity in low-income countries. PLoS Biol (2009) 0.99